4
Registered trials
4
Recruiting
1
Unique sponsors
1
Unique IMPs
4
Commercial trials
Drug classes (ATC)
—
ATC code not specified
4
Mechanism of action (INN-stem analysis)
Unknown / small molecule
1 substance
Phase III:
4
Phase III
4 trials-
RecruitingBristol-Myers Squibb Services Unlimited Company CommercialTROSPIUM CHLORIDE, XANOMELINE TARTRATE
-
RecruitingBristol-Myers Squibb Services Unlimited Company CommercialTROSPIUM CHLORIDE, XANOMELINE TARTRATE
-
RecruitingBristol-Myers Squibb Services Unlimited Company CommercialTROSPIUM CHLORIDE, XANOMELINE TARTRATE
-
RecruitingBristol-Myers Squibb Services Unlimited Company CommercialTROSPIUM CHLORIDE, XANOMELINE TARTRATE
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Bristol-Myers Squibb Services Unlimited Company | Commercial | 4 | Phase III | 4 |
New trials by year
2025
3
2026
1